FXR/TGR5 Dual Agonist INT-767 Reduces NAS & Fibrosis & Improves Plasma & Hepatic Lipid Profiles in the AMLN Mouse Model of Diet-induced & Biopsy-confirmed NASH

被引：0
|
作者：
Roth, Jonathan [1 ]
Feigh, Michael [2 ]
Herrmann, Sibylle [3 ]
机构：
[1] Intercept Pharmaceut Inc, San Diego, CA USA
[2] Gubra, Horsholm, Denmark
[3] Intercept Pharma Europe, London, England
来源：
SWISS MEDICAL WEEKLY | 2017年 / 147卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PH4
引用
收藏
页码：20S / 20S
页数：1
相关论文
共 40 条
  • [1] The FXR/TGR5 Dual Agonist INT-767 Reduces NAFLD Activity Score and Fibrosis Stage and Improves Plasma and Hepatic Lipid Profiles in the GUBRA-AMLN Mouse Model of Diet-induced and Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)
    Roth, Jonathan
    Feigh, Michael
    Veidal, Sanne Skovgaard
    Rigbolt, Kristoffer
    Jelsing, Jacob
    Vrang, Niels
    Young, Mark
    HEPATOLOGY, 2016, 64 : 752A - 753A
  • [2] Detailed Analyses of the Antifibrotic effects of INT-767, a dual FXR/TGR5 agonist, in an obese mouse model of diet-induced and biopsy-confirmed NASH
    Veidal, Sanne Skovgaard
    Feigh, Michael
    Hansen, Henrik B.
    Jelsing, Jacob
    Vrang, Niels
    Petitjean, Matthieu
    Chen, Li
    Young, Mark
    Roth, Jonathan D.
    HEPATOLOGY, 2017, 66 : 1044A - 1044A
  • [3] The FXR/TGR5 dual agonist INT-767 prevents and reverses Western diet-induced NASH and modulates major lipid metabolic pathways in mice
    Wang, Xiaoxin
    Libby, Andrew
    Ranjit, Suman
    Wang, Dong
    Luo, Yuhuan
    Orlicky, David J.
    McManaman, James
    Dobrinskikh, Evgenia
    Gratton, Enrico
    Young, Mark
    Adorini, Luciano
    Levi, Moshe
    HEPATOLOGY, 2016, 64 : 761A - 762A
  • [4] Prophylactic and therapeutic hepatoprotective effects of the dual FXR/TGR5 agonist INT-767 in the GAN diet-induced ob/ob mouse model of advanced MASH with progressive fibrosis
    Nohr-Meldgaard, Jacob
    Pors, Susanne
    Olsen, Rebecca Wendelbo
    Hansen, Henrik B.
    Feigh, Michael
    JOURNAL OF HEPATOLOGY, 2024, 80 : S566 - S567
  • [5] INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed nonalcoholic steatohepatitis
    Roth, Jonathan D.
    Feigh, Michael
    Veidal, Sanne S.
    Fensholdt, Louise K. D.
    Rigbolt, Kristoffer T.
    Hansen, Henrik H.
    Chen, Li C.
    Petitjean, Mathieu
    Friley, Weslyn
    Vrang, Niels
    Jelsing, Jacob
    Young, Mark
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (02) : 195 - 210
  • [6] Seladelpar Improves Hepatic Steatohepatitis and Fibrosis in a Diet-Induced and Biopsy-Confirmed Mouse Model of Nash
    Choi, Yun-Jung
    Song, Jiangao
    Johnson, Jeff D.
    Petersen, Pia S.
    Veidal, Sanne
    Feigh, Michael
    Hellerstein, Marc
    McWherter, Charles
    HEPATOLOGY, 2018, 68 : 755A - 755A
  • [7] The dual FXR/TGR5 agonist INT-767 counteracts non-alcoholic steatohepatitis in a rabbit model of high fat diet-induced metabolic syndrome
    Vignozzi, Linda
    Cellai, Ilaria
    Filippi, Sandra
    Comeglio, Paolo
    Sarchielli, Erica
    Morelli, Annamaria
    Maneschi, Elena
    Vannelli, Gabriella Barbara
    Adorini, Luciano
    Maggi, Mario
    HEPATOLOGY, 2015, 62 : 645A - 645A
  • [8] THE DUAL FXR/TGR5 AGONIST INT-767 COUNTERACTS NONALCOHOLIC STEATOHEPATITIS AND ERECTILE DYSFUNCTION IN A RABBIT MODEL OF HIGH FAT DIET-INDUCED METABOLIC SYNDROME
    Vignozzi, L.
    Cellai, I
    Filippi, S.
    Comeglio, P.
    Sarchielli, E.
    Morelli, A.
    Maneschi, E.
    Vannelli, G. B.
    Adorini, L.
    Maggi, M.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (04): : E143 - E144
  • [9] Comparative efficacy of obeticholic acid and INT-767 in the Gubra mouse NASH model of diet induced and biopsy-confirmed nonalcoholic steatohepatitis (NASH)
    Roth, Jonathan D.
    Feigh, Michael
    Veidal, Sanne Skovgaard
    Fensholdt, Louise Kathrine Due
    Vrang, Niels
    Young, Mark
    HEPATOLOGY, 2017, 66 : 1060A - 1060A
  • [10] The dual FXR/TGR5 agonist INT-767 inhibits nonalcoholic steatohepatitis development in a rabbit model of metabolic syndrome
    Comeglio, Paolo
    Filippi, Sandra
    Cellai, Ilaria
    Maneschi, Elena
    Corcetto, Francesca
    Como, Chiara
    Morelli, Annamaria
    Adorini, Luciano
    Maggi, Mario
    Vianozzi, Linda
    HEPATOLOGY, 2016, 64 : 758A - 759A
1234